Spine Radiology
ARTICLE 11
Spine Radiology · Neoplasms

Osteoid Osteoma and Osteoblastoma

Painful posterior-element lesions

Section · Neoplasms Updated · March 2026 Read · ~4 min

Osteoid Osteoma and Osteoblastoma

Definition

Osteoid osteoma and osteoblastoma are closely related benign bone-forming tumors that share histological features but differ in size, behavior, and clinical presentation. They have a predilection for the posterior elements of the spine, particularly in young patients.

Osteoid Osteoma

Definition

A small (<1.5 cm) benign bone-forming tumor characterized by a central nidus surrounded by reactive sclerosis. In the spine, it accounts for approximately 10% of all osteoid osteomas.

Clinical Features

Imaging

CT (best modality for characterization): - Small, round, low-attenuation nidus (<1.5 cm) in the posterior elements (pedicle, lamina, articular process) - Dense reactive sclerosis surrounding the nidus - The nidus may contain a central dot of calcification

MRI: - The nidus may be difficult to see due to surrounding edema and reactive changes - Extensive bone marrow and soft tissue edema can mimic an aggressive or malignant process - Post-contrast: the nidus enhances

Bone scan: - "Double density" sign — intense focal uptake at the nidus with a surrounding zone of less intense uptake

Treatment

Osteoblastoma

Definition

A larger (>1.5–2 cm) benign bone-forming tumor histologically similar to osteoid osteoma but with more aggressive behavior. The spine is the most common location for osteoblastoma (30–40% of cases).

Imaging

Treatment

Clinical Pearl

A young patient with painful scoliosis and night pain relieved by NSAIDs should be evaluated for osteoid osteoma of the posterior elements. The concavity of the scoliosis is on the side of the tumor. CT is the best modality to identify the nidus — MRI may be misleading because extensive surrounding edema can suggest a more aggressive lesion.

Key Points

References

  1. Gangi A, Alizadeh H, Wong L, Buy X, Dietemann JL, Roy C. Osteoid osteoma: percutaneous laser ablation and follow-up in 114 patients. Radiology. 2007;242(1):293-301. Available from: https://pubmed.ncbi.nlm.nih.gov/17122219/
  2. Iyer RS, Chapman T, Chew FS. Pediatric bone imaging: diagnostic imaging of osteoid osteoma. AJR Am J Roentgenol. 2012;198(5):1039-52. Available from: https://ajronline.org/doi/10.2214/AJR.10.7313
  3. Chai JW, Hong SH, Choi JY, Koh YH, Lee JW, Choi JA, et al. Radiologic diagnosis of osteoid osteoma: from simple to challenging findings. RadioGraphics. 2010;30(3):737-49. Available from: https://pubs.rsna.org/doi/abs/10.1148/rg.303095120
  4. Noordin S, Allana S, Hilal K, Nadeem N, Lakdawala R, Sadruddin A, et al. Osteoid osteoma: contemporary management. Orthop Rev (Pavia). 2018;10(3):7496. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3522328/
  5. Carneiro BC, Da Cruz IAN, Ormond Filho AG, Silva IP, Guimarães JB, Silva FD, et al. Osteoid osteoma: the great mimicker. Insights Imaging. 2021;12(1):32. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7940467/
  6. Zhang Y, Lin H, Pi Y, Cheng X, Wang Z. Imaging algorithm and multimodality evaluation of spinal osteoblastoma. BMC Musculoskelet Disord. 2020;21(1):240. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7158089/
  7. Galgano MA, Goulart CR, Iwenofu H, Chin LS, Lavelle W, Mendel E. Osteoblastomas of the spine: a comprehensive review. Neurosurg Focus. 2016;41(2):E4. Available from: https://thejns.org/focus/view/journals/neurosurg-focus/41/2/article-pE4.xml
  8. Limaiem F, Byerly DW, Singh R. Osteoblastoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK536954/
  9. Tsoumakidou G, Thénint MA, Garnon J, Buy X, Steib JP, Gangi A. Percutaneous image-guided laser photocoagulation of spinal osteoid osteoma: a single-institution series. Radiology. 2016;278(3):936-43.
  10. Sagoo NS, Haider AS, Palmisciano P, et al. Radiofrequency ablation for spinal osteoid osteoma: a systematic review of safety and outcomes. Surg Oncol. 2022;41:101747. Available from: https://pubmed.ncbi.nlm.nih.gov/35358911/